Status:
WITHDRAWN
Dexmedetomidine Effects on Microelectrode Recording in Deep Brain Stimulation
Lead Sponsor:
Vanderbilt University
Conditions:
Parkinson's Disease
Essential Tremor
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
To test the hypothesis that sedation induced by Dexmedetomidine at levels appropriate for awake, DBS surgery has no significant effect on electrophysiological parameters of DBS micro-electrode recordi...
Detailed Description
Deep brain stimulator (DBS) implants are used in the treatment of medically refractory movement disorders such as Parkinson's disease, essential tremor and dystonia. Because of the uniqueness of each ...
Eligibility Criteria
Inclusion
- Any patient who has agreed to undergo DBS implantation.
Exclusion
- Patients who fail recommendation for DBS surgery discussed in Vanderbilt University Movement Disorder Clinical Conference.
- Patients not consented for DBS surgery.
- Patients or legal guardians not able to provide informed consent.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00608231
Start Date
January 1 2008
End Date
January 1 2012
Last Update
July 1 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232